(Q44225524)

1 December 2017

title

Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: a strategy for solid tumor therapy (Model C). (English)

1 reference

1 December 2017

0 references

Huaping Liu

1

1 reference

1 December 2017

Niramol Savaraj

series ordinal

2

1 reference

1 December 2017

Waldemar Priebe

series ordinal

3

1 reference

1 December 2017

Theodore J Lampidis

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

1 December 2017

published in

Biochemical Pharmacology

1 reference

1 December 2017

volume

64

1 reference

1 December 2017

issue

12

1 reference

1 December 2017

page(s)

1745-1751

1 reference

Rho(0) tumor cells: a model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901456-9

Hypersensitization of tumor cells to glycolytic inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901456-9

Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901456-9

Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901456-9

Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901456-9

Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901456-9

Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901456-9

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901456-9

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901456-9

Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901456-9

Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901456-9

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901456-9

Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901456-9

10.1016/S0006-2952(02)01456-9

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference